Diasorin Stock: price and insider trades · Italy

Diasorin, classified in the Health Care sector, is a listed company based in Saluggia, Italy, founded in 2000. Its insiders report their share dealings to Consob. The last twelve months, up to 18 October 2026, brought 14 filings signed by 7 insiders.

Every open-market trade in the period is a purchase: 7 purchases worth €150.6M, from 6 insiders, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €150.1M, the purchase published on 23 July 2026 is the largest of the period (3.9% of market cap). On the buying side, the filings list 6 board members among the declarants.

The most recent open-market purchase was published on 23 July 2026, 86 days ago. Between a trade and the moment it shows up on Consob, the median delay is 4 days. Under the Market Abuse Regulation, managers have three business days to notify their trades.

For context, the typical company on the same exchange (median of 224 companies) published 3 filings over the same period, against 14 filings here. Over the whole record (from 2023), the tally stands at 7 purchases and 33 sales.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by Consob and describes the past, not future prices; it is not investment advice.